increas
global
popul
worldwid
exchang
infect
rna
virus
expand
huge
impact
public
health
new
infect
emerg
almost
everi
year
pandem
flu
west
nile
enceph
sever
acut
respiratori
syndrom
middl
east
respiratori
syndrom
chikungunya
ebola
tropic
fever
expand
dengu
zika
even
previous
control
diseas
reemerg
measl
poliomyel
although
sever
effici
vaccin
rna
virus
use
human
medicin
still
lack
potent
therapeut
treatment
major
viral
infect
well
ration
strategi
creat
effici
new
vaccin
recent
progress
understand
cellular
pathway
control
viral
replic
suggest
modul
host
cell
function
earli
upon
viral
infect
could
inhibit
larg
panel
rna
virus
cheng
et
al
shirey
et
al
essaad
et
al
guo
et
al
lucashourani
et
al
rigilik
receptor
rlr
appear
locat
frontlin
evolutionari
race
virus
host
immun
system
vasseur
et
al
cellular
protein
detect
invas
viral
nucleic
acid
speci
insid
cytoplasm
initi
innat
immun
respons
viral
infect
limit
viru
replic
trigger
adequ
adapt
immun
respons
errett
gale
rlr
signal
oper
ubiquit
henc
rlr
repres
attract
strategi
antivir
therapi
vaccin
develop
rlr
famili
pattern
recognit
receptor
prr
group
cytosol
rna
helicas
identifi
viral
rna
nonself
via
bind
pathogenassoci
molecular
pattern
pamp
motif
date
three
rlr
member
identifi
rigi
retino
acidinduc
genei
melanomadifferentiationassoci
gene
laboratori
genet
physiolog
review
loo
gale
dixit
kagan
share
number
structur
similar
includ
organ
three
distinct
domain
figur
ntermin
region
consist
tandem
caspas
activ
recruit
domain
card
ii
central
dexdh
box
rna
helicas
domain
capac
hydrolyz
atp
bind
rna
iii
repressor
domain
rd
embed
within
carboxytermin
domain
ctd
rna
helicas
interact
particular
signatur
viral
rna
still
unknown
upon
ligand
recognit
rlr
bear
card
domain
rigi
undergo
conform
chang
permit
card
domain
recruit
oligomer
mav
either
peroxisom
mitochondrion
activ
signal
pathway
lead
transloc
transcript
factor
nfkb
nucleu
initi
express
secret
type
ifn
proinflamatori
cytokin
secret
type
ifn
bind
receptor
activ
jakstat
signal
pathway
induc
express
ifnstimul
gene
isg
bear
ifnstimul
respons
element
isr
de
veer
et
al
viru
mean
subvert
interferon
pathway
infect
tissu
turn
antivir
state
lead
apoptosi
infect
cell
ii
limit
propag
viru
express
isg
neighbour
cell
iii
gener
cytokin
storm
trigger
specif
adapt
immun
respons
well
favour
immun
cell
infiltr
cardiovascular
system
member
rlr
famili
implic
recognit
varieti
virus
dixit
kagan
goubau
et
al
patel
garciasastr
rigi
confer
recognit
hepacivirus
member
paramyxovirida
rhabdovirida
orthomyxovirida
famili
exampl
copyback
defectiveinterf
di
genom
produc
numer
negativesens
rna
virus
specif
associ
rigi
activ
ifn
induct
strahl
et
al
baum
et
al
komarova
et
al
rung
et
al
detect
member
picornavirida
calicivirida
coronavirida
flavivirida
reovirida
arenavirida
detect
rigi
act
posit
neg
upon
activ
differ
virus
moresco
beutler
deddouch
et
al
sever
dna
virus
also
report
activ
rlr
pathway
includ
herp
simplex
adenoviru
epsteinbarr
viru
vaccinia
viru
hepat
b
viru
choi
et
al
sato
et
al
case
dna
virus
poli
da
dt
dna
sequenc
trigger
ifn
respons
rna
polymeras
iii
transcript
detect
rigi
ablass
et
al
chiu
et
al
surprisingli
intracellular
bacteria
listeria
monocytogen
legionella
pneumophila
salmonella
typhimurium
shigella
flexneri
also
activ
type
ifn
respons
rigi
signal
plasmodium
rna
sens
malaria
infect
chiu
et
al
monro
et
al
liehl
et
al
patel
garciasastr
although
human
rlr
recent
receiv
consider
attent
knowledg
nobodi
yet
simultan
explor
viral
rna
partner
bind
three
known
rlr
experiment
condit
addit
studi
characteris
molecular
featur
rlr
ligand
presenc
viral
infect
baum
et
al
deddouch
et
al
rung
et
al
thu
difficult
exist
observ
get
clear
pictur
biolog
ligand
rlr
ii
function
differ
rlr
studi
virushost
rnaprotein
interact
viral
infect
previous
develop
valid
highthroughput
riboproteom
approach
base
onestreptag
protein
affin
purif
nextgener
sequenc
ng
komarova
et
al
protocol
allow
explor
biolog
activ
macromolecular
complex
within
infect
cell
appli
method
studi
viral
rna
signatur
sens
rigi
cytosol
receptor
upon
infect
neg
positivesens
rna
virus
studi
provid
better
understand
mechan
role
rlr
associ
rna
help
conceiv
new
therapeut
approach
modul
innat
immun
new
vaccin
adjuv
identifi
compar
rlr
viral
rna
partner
upon
infect
differ
virus
gener
human
cell
line
stabli
express
onestreptag
rigi
protein
figur
onestrep
tag
provid
reliabl
rapid
effici
protocol
ribonucleoprotein
rnp
protein
complex
purif
komarova
et
al
tag
rlr
ntermin
sinc
previou
studi
shown
ad
ntermin
tag
rlr
neg
effect
function
interact
rna
ligand
pichlmair
et
al
rehwinkel
et
al
zhang
et
al
deddouch
et
al
cell
line
assign
strlr
cell
strigi
respect
addit
stabl
cell
line
assign
stch
express
cherri
protein
instead
tag
rlr
gener
neg
control
allow
subtract
nonspecif
rna
bind
use
rtqpcr
analysi
affin
purif
follow
western
blot
analysi
valid
express
tag
rlr
stabl
cell
line
figur
analys
function
profil
strlr
cell
line
upon
transfect
rigi
agonist
use
classic
promot
activ
assay
figur
observ
transfect
cell
agonist
poli
c
elicit
increas
ifni
respons
contrast
transfect
cell
rigi
agonist
triphosphaterna
mask
ifni
respons
figur
observ
accord
previou
studi
show
overexpress
simultan
coexpress
synerg
type
ifn
respons
upon
activ
mdaspecif
agonist
upon
infect
encephalomyocard
viru
emcv
brun
et
al
overexpress
also
previous
found
inhibit
rigi
signal
moresco
beutler
altogeth
demonstr
three
stabl
celllin
establish
express
tag
rlr
function
purifi
affin
chromatographi
test
whether
overexpress
rlr
influenc
effici
rna
viru
replic
infect
strlr
stabl
cell
line
repres
neg
positivesens
rna
viru
measl
viru
mv
chikungunya
viru
chikv
respect
mv
belong
famili
paramyxovirida
order
mononegaviral
often
consid
prototyp
member
negativesens
rna
virus
mv
genom
use
templat
viral
polymeras
replic
viral
genom
synthes
mrna
molecul
encod
six
structur
protein
n
p
f
h
l
two
nonstructur
virul
factor
v
c
determin
kinet
mv
replic
strlr
cell
use
recombin
mv
express
firefli
luciferas
fluc
gene
viral
genom
komarova
et
al
observ
low
multipl
infect
moi
mv
replic
slightli
less
effici
strigi
cell
two
cell
line
figur
mv
replic
also
monitor
immunostain
mv
nucleoprotein
mvn
flow
cytometri
analysi
hr
postinfect
figur
observ
viral
replic
slightli
reduc
cell
express
addit
copi
rigi
protein
particularli
low
moi
chikv
member
famili
togavirida
positivesens
singlestrand
rna
genom
nonstructur
protein
directli
translat
viral
genom
earli
stage
viral
replic
wherea
structur
protein
capsid
c
envelop
glycoprotein
ion
channel
protein
encod
subgenom
mrna
mrna
late
viral
cycl
assess
chikv
replic
kinet
tag
rlr
cell
line
use
molecular
clone
chikv
chikvrluc
differ
moi
viru
report
renilla
luciferas
rluc
gene
express
integr
part
nonstructur
polyprotein
chikv
chikvrluc
allow
monitor
earli
stage
viral
replic
henrik
gad
et
al
chikvrluc
replic
cell
line
detect
strong
rluc
express
classic
growth
kinet
viru
figur
howev
similarli
mv
observ
chikv
replic
reduc
low
moi
strigi
cell
observ
confirm
measur
accumul
glycoprotein
late
viral
product
strlr
cell
infect
wt
chikv
viral
replic
delay
cell
express
addit
copi
rigi
protein
figur
experi
demonstr
neg
positivesens
rna
virus
replic
cell
express
addit
copi
tag
rlr
thu
strlr
cell
provid
suitabl
condit
studi
rna
ligand
rlr
within
infect
cell
show
figur
three
strlr
effici
infect
mv
moi
hr
postinfect
mvn
posit
cell
previous
observ
extrem
valuabl
virushost
interact
network
condit
infect
komarova
et
al
therefor
choos
condit
purifi
rlr
protein
complex
mv
rna
ligand
case
chikv
infect
distinguish
earli
late
stage
viru
replic
inde
believ
earli
stage
viral
cycl
dsrna
intermediari
product
sens
rlr
receptor
activ
type
ifn
signal
chikv
nonstructur
protein
translat
viral
genom
replic
perform
earli
step
replic
stage
monitor
use
chikvrluc
observ
rluc
accumul
start
hr
postinfect
strlr
stch
cell
figur
c
left
axi
addit
dsrna
presenc
assess
cell
infect
wt
chikv
use
intracellular
stain
antidsrna
antibodi
flow
cytometri
analysi
observ
dsrna
accumul
start
hr
postinfect
figur
right
axi
effici
translat
structur
glycoprotein
correspond
late
stage
chikv
replic
observ
hr
postinfect
three
strlr
cell
line
figur
c
right
axi
schemat
represent
three
technic
approach
repres
figur
supplement
experi
show
purif
chikv
rna
ligand
complex
rlr
perform
hr
postinfect
chikv
moi
figur
purifi
rna
associ
rlr
upon
infect
neg
positivesens
rna
virus
strlr
cell
infect
mv
chikv
cell
harvest
hr
mv
hr
chikv
postinfect
rlr
togeth
associ
partner
purifi
total
cell
lysat
affin
chromatographi
see
materi
method
rna
molecul
interact
rlr
neg
control
ch
extract
design
rlrrna
neg
control
chrna
test
capac
rna
molecul
induc
ifnmedi
antivir
respons
rna
sampl
extract
rigi
ch
transfect
report
cell
stabli
express
fluc
gene
control
promot
sequenc
contain
five
ifnstimul
respons
element
isr
lucashourani
et
al
observ
rna
ligand
purifi
rigi
receptor
presenc
mv
chikv
infect
increas
immunostimulatori
activ
comparison
rna
ligand
figur
b
expect
rna
purifi
neg
control
ch
provid
poor
immunostimulatori
activ
experiment
setup
well
rna
purifi
rlr
complex
absenc
viral
infect
figur
result
demonstr
rna
ligand
bound
strlr
specif
enrich
immunoact
rna
molecul
experiment
strategi
sensit
enough
isol
rlrspecif
rna
ligand
neg
positivesens
rna
virus
within
infect
cell
evalu
requir
rigi
ifn
respons
mv
chikv
deplet
cell
rigi
via
transduct
lentivir
vector
express
shrna
receptor
control
shrna
level
rigi
mrna
puromycinresist
transduc
cell
popul
assess
quantit
rtqpcr
silenc
decreas
rigi
level
respect
figur
cell
assign
stingshrigi
stingshneg
respect
see
materi
method
upon
mv
infect
cell
rigi
receptor
silenc
strongli
impair
isr
promot
activ
silenc
affect
signal
figur
independ
mvv
protein
known
subvert
rlr
respons
interact
andrejeva
et
al
child
et
al
motz
et
al
viru
delet
v
protein
behav
similarli
upon
chikv
infect
fail
detect
activ
isr
promot
condit
previous
establish
hr
postinfect
figur
analysi
show
increas
chikv
moi
reduc
fluc
express
control
isr
promot
silenc
cell
line
even
earli
time
postinfect
figur
oldworld
alphavirus
known
shutdown
transcript
infect
cell
garmashova
et
al
white
et
al
akhrymuk
et
al
et
al
howev
chikv
infect
induc
phosphoryl
nuclear
transloc
white
et
al
therefor
use
western
blot
analysi
rlrdepend
type
ifn
signal
evalu
phosphoryl
chikvinfect
stingshrlr
cell
interestingli
observ
cell
defici
rigi
longer
phosphoryl
figur
data
valid
import
role
rigi
viral
sens
mv
chikv
infect
use
experiment
set
fail
valid
implic
type
ifn
activ
result
contradict
fact
immunoact
rna
ligand
copurifi
either
mv
chikvinfect
cell
possess
slight
immunostimulatori
activ
figur
b
clarifi
question
proceed
ng
rlrassoci
rna
identifi
natur
rna
molecul
bound
rlr
unbias
manner
strandspecif
ng
analysi
perform
use
illumina
technolog
distinguish
rlrassoci
rna
molecul
nonspecif
bind
bead
coaffin
purif
experi
perform
parallel
stch
cell
experi
perform
triplic
approxim
million
read
nucleotid
length
obtain
sequenc
sampl
map
viral
genom
gave
mv
genom
coverag
rang
also
perform
ng
analysi
total
rna
sampl
total
rna
result
provid
classic
exampl
transcript
gradient
characterist
order
mononegaviral
inde
mv
transcript
initi
singl
promot
end
genom
gene
junction
viru
rnadepend
rnapolymeras
either
falloff
continu
transcript
downstream
gene
cattaneo
et
al
plumet
et
al
due
gradient
transcript
mv
promoterproxim
gene
express
effici
promoterdist
gene
normal
read
count
see
bellow
mv
genom
shown
figur
supplement
first
posit
read
taken
account
perform
statist
analysi
read
rlr
enrich
rlrrna
sampl
compar
chrna
sampl
lack
enrich
total
rna
rlr
sampl
test
compar
total
rna
ch
control
sampl
perform
differenti
analys
rlrrna
chrna
one
hand
total
rlr
rna
total
ch
rna
hand
normal
differenti
analys
perform
r
team
packag
pvalu
adjust
perform
accord
benjamini
hochberg
bh
procedur
benjamini
hochberg
posit
consid
significantli
enrich
adjust
pvalu
lower
importantli
differ
except
strigi
cell
total
rna
profil
strlr
cell
upon
infect
mv
supplementari
file
differ
taken
consider
upon
statist
analysi
distribut
normal
read
count
match
mv
genom
sequenc
repres
along
viral
genom
x
axi
correspond
possibl
posit
viral
genom
axi
show
normal
number
read
begin
posit
figur
distribut
normal
sequenc
read
rlr
sampl
collect
mv
infect
differ
lot
three
cytosol
receptor
inde
ng
data
analysi
show
specif
associ
rna
sequenc
posit
polar
like
correspond
mvn
mrna
readthrough
transcript
mv
leader
region
contain
n
code
sequenc
figur
associ
rna
sequenc
repres
short
part
n
code
region
also
enrich
l
genederiv
rna
posit
neg
polar
figur
surprisingli
fail
detect
rigi
specif
read
align
mv
genom
shown
unexpect
sinc
abovepres
silenc
experi
rigi
import
three
rlr
sensor
innat
immun
activ
upon
mv
infect
figur
thu
perform
second
rigi
purif
ng
experi
second
rigirna
sequenc
viral
genom
coverag
rang
obtain
similar
read
profil
short
posit
along
mv
genom
statist
enrich
rigirna
sampl
figur
failur
detect
specif
mv
rna
ligand
rigi
could
explain
lack
rigispecif
mv
rna
ligand
defici
tag
rigi
protein
rna
ligand
purif
mv
copyback
di
genom
known
interactor
rigi
therefor
look
presenc
di
rna
molecul
strigi
cell
infect
mv
use
univers
copyback
di
genom
specif
primer
rtpcr
analysi
fail
detect
copyback
di
rna
infect
strigi
cell
figur
interestingli
cell
infect
viru
defici
v
protein
two
dna
fragment
approxim
kb
amplifi
total
rna
sampl
use
copyback
di
genom
specif
primer
figur
furthermor
sequenc
analysi
reveal
kb
rtpcr
amplicon
contain
copyback
dirna
featur
inde
nucleotidelong
di
genom
includ
genom
trailer
tr
revers
complement
tr
sequenc
extrem
exact
complementari
extrem
nucleotid
abl
hybrid
form
stemloop
structur
figur
supplement
sequenc
analysi
amplicon
suggest
could
correspond
mosaic
type
mv
di
genom
marriott
dimmock
immunostimulatori
activ
rigirna
purifi
infect
cell
demonstr
signific
increas
isr
stimul
compar
rigirna
purifi
mv
infect
cell
figur
interestingli
immunostimulatori
activ
total
rna
purifi
mv
infect
strigi
cell
similar
figur
supplement
sinc
copyback
di
genom
known
interactor
rigi
use
infect
verifi
effici
specif
rigi
ligand
purif
strigi
cell
rigirna
analys
ng
control
use
chrna
sampl
purifi
parallel
experi
previous
experi
perform
triplic
sequenc
read
map
mv
genom
statist
analysi
perform
expect
normal
read
count
repres
along
mv
genom
vast
major
read
align
end
genom
sequenc
posit
neg
polar
figur
mv
genom
region
perfectli
correspond
ntslong
copyback
di
genom
character
figur
supplement
data
clearli
confirm
role
rigi
sens
copyback
di
rna
suggest
role
mvv
protein
control
di
genom
format
also
demonstr
strigi
cell
line
potent
tool
purifi
specif
rna
ligand
rigi
upon
infect
evalu
augc
composit
rna
sequenc
found
specif
interact
three
rlr
upon
infect
mv
perform
addit
bioinformat
analysi
ng
data
au
content
calcul
slide
window
nt
one
nucleotid
step
size
compar
mean
count
within
nt
window
figur
b
c
demonstr
au
composit
specif
rna
partner
result
show
rigi
preferenti
bind
aurich
rna
region
mv
genom
di
genom
gener
upon
infect
use
mfold
algorithm
perform
silico
analysi
potenti
form
rna
secondari
structur
differ
mv
genom
region
observ
end
genom
begin
fragment
possess
region
lower
free
energi
figur
similar
protocol
ng
analysi
rlrspecif
rna
partner
appli
chikvinfect
strlr
cell
approxim
million
read
nucleotid
length
obtain
sequenc
sampl
map
chikv
genom
gave
viral
genom
coverag
rang
perform
statist
analysi
mv
sampl
interestingli
time
total
rna
profil
strlr
cell
infect
chikv
differ
respect
neg
control
stch
cell
line
supplementari
file
differ
taken
consider
upon
statist
analysi
distribut
normal
read
count
match
chikv
genom
sequenc
repres
along
viral
genom
x
axi
correspond
possibl
posit
viral
genom
axi
show
normal
number
read
begin
posit
figur
first
studi
ng
data
obtain
total
rna
sampl
visual
inspect
align
read
chikv
genom
show
enrich
region
correspond
chikv
subgenom
rna
figur
supplement
inde
previou
studi
shown
alphavirus
subgenom
rna
abund
genom
cytoplasm
infect
cell
strauss
strauss
pushko
et
al
although
averag
number
read
obtain
chikv
genom
rlr
sampl
higher
mv
rlrrna
statist
analysi
sampl
fail
show
specif
enrich
read
correspond
chikv
genom
data
shown
contrast
rigirna
sampl
observ
specif
enrich
sens
rna
read
correspond
untransl
region
utr
chikv
genom
figur
thu
protocol
rlrassoci
rna
ligand
purif
allow
us
observ
cytosol
sensor
specif
rna
profil
upon
infect
differ
rna
virus
confirm
rel
amount
rlrassoci
viral
rna
use
qpcr
numer
primer
align
mv
chikv
genom
design
figur
supplementari
file
obtain
enrich
mrna
code
mvn
protein
sampl
compar
chrna
sampl
qpcr
analysi
use
three
differ
probe
align
begin
end
mvn
mrna
figur
valid
rna
like
repres
transcript
code
mvn
protein
figur
neg
control
three
mv
mrna
code
p
h
protein
look
found
enrich
sampl
figur
valid
specif
bind
end
code
region
n
gene
rna
fragment
locat
farthest
end
n
mrna
significantli
enrich
use
qpcr
figur
valid
specif
interact
rigi
end
chikv
genom
use
pair
primer
detect
genom
rna
three
other
detect
genom
subgenom
rna
locat
end
genom
figur
inde
primer
locat
end
genom
significantli
enrich
compar
set
viral
specif
primer
cellular
housekeep
gene
figur
furthermor
analys
immunostimulatori
activ
rlrspecif
region
mv
genom
transfect
vitro
transcrib
rna
fragment
epitheli
cell
permiss
mv
identifi
sequenc
end
n
mrna
enhanc
capac
activ
ifn
respons
figur
final
valid
classic
coimmunoprecipit
coip
approach
result
obtain
strlr
purif
techniqu
infect
typic
viruspermiss
immun
cell
model
acut
monocit
leukemia
cell
line
perform
rna
isol
coip
rna
analysi
qpcr
experi
valid
predisposit
bind
mvn
code
region
figur
supplement
result
good
agreement
ng
result
confirm
relev
highthroughput
protocol
studi
viral
rna
signatur
sens
rigi
cytosol
receptor
upon
infect
differ
rna
virus
rlr
locat
frontlin
evolutionari
race
virus
host
immun
system
cytoplasm
protein
detect
invas
viral
rna
cytoplasm
infect
cell
trigger
innat
immun
inflammatori
respons
necessari
limit
viral
replic
initi
specif
adapt
immun
respons
studi
rlr
specif
viral
rna
ligand
perform
absenc
product
viru
infect
review
see
yoneyama
et
al
studi
base
transfect
within
cell
rna
come
infect
cell
express
viralcod
sequenc
plasmid
transfect
vitro
transcrib
rna
synthet
rlr
agonist
poli
c
recent
character
rna
ligand
rlr
presenc
activ
viral
infect
sendai
influenza
virus
mv
emcv
ng
appli
rna
isol
infect
cell
coip
studi
methodolog
approach
base
either
photo
activableribonucleosideenhanc
crosslink
coip
parclip
simpl
coip
follow
ng
use
approach
sendai
influenza
virus
rigi
specif
rna
partner
analys
baum
et
al
emcv
rna
partner
sequenc
deddouch
et
al
mv
rigi
specif
rna
partner
studi
simultan
rung
et
al
disadvantag
rnaprotein
isol
coip
approach
reli
avail
highaffin
antibodi
protein
interest
ii
often
lack
appropri
neg
control
neg
control
antibodi
differ
affin
direct
protein
absent
cell
easili
underestim
background
nois
gener
coip
follow
ng
also
parclip
methodolog
incorpor
nucleosid
analogu
within
rna
activ
cycl
viral
replic
could
chang
molecular
properti
viral
cellular
rna
thu
creat
artifici
environ
overcom
problem
appli
onestreptag
fusion
protein
affin
chromatographi
purifi
rlr
gener
three
singleclon
stabl
cell
line
express
either
tag
rigi
figur
addit
stabl
cell
line
express
ch
protein
fuse
onestreptag
use
control
nonspecif
bind
tool
allow
studi
three
rlr
set
character
specif
viral
rna
ligand
cours
infect
inde
isol
specif
rlr
rna
ligand
cell
infect
mv
chikv
respect
neg
positivesens
rna
viru
three
biolog
replic
perform
rlr
appropri
neg
control
chrna
allow
subtract
nonspecif
bind
perform
rigor
statist
analys
despit
fact
cell
overexpress
one
rlr
suscept
infect
differ
rna
virus
figur
appli
multipl
function
test
determin
best
condit
strlr
cell
infect
figur
valid
effici
rlrspecif
rna
ligand
purif
allow
extract
immunoact
rna
molecul
figur
consist
previou
studi
observ
rigirna
provid
stronger
immunostimulatori
activ
comparison
molecul
ikegam
et
al
rung
et
al
experiment
setup
show
rna
similar
immunostimulatori
activ
rigirna
figur
thu
two
infect
immunoact
rna
ligand
purifi
rigi
chikv
infect
specif
rna
ligand
cytosol
rlr
establish
yet
inflammatori
respons
nonhematopoiet
cell
known
depend
mav
adaptor
molecul
necessari
rigi
howev
two
receptor
involv
sens
chikv
still
unknown
schilt
et
al
found
rigi
specif
interact
utr
chikv
genom
despit
higher
coverag
chikv
genom
compar
mv
genom
ng
data
fail
observ
specif
enrich
chikv
read
receptor
observ
rigi
specif
interact
chikv
utr
promis
figur
inde
utr
positivesens
rna
virus
alreadi
shown
particularli
immunoact
saito
et
al
schnell
et
al
kell
et
al
chikv
utr
contain
multipl
nucleotidelong
repeat
sequenc
element
form
dsrna
structur
possibl
target
rigi
zhang
et
al
interestingli
utr
recent
describ
region
particularli
sensit
evolutionari
pressur
exert
mosquito
vector
chen
et
al
thu
observ
mammalian
host
rigi
target
viral
region
knowledg
first
time
rigi
affin
end
positivesens
rna
viru
demonstr
physiolog
condit
mv
infect
compar
ng
data
previous
publish
rigi
use
parclip
coupl
ng
approach
rung
et
al
interestingli
studi
rung
et
al
data
show
rlr
preferenti
interact
mvn
mvl
deriv
rna
ii
rigi
interact
viral
rna
neg
positivesens
polar
origin
mv
copyback
di
genom
figur
rung
et
al
howev
observ
sever
discrep
found
rigi
specif
interact
mvn
code
sequenc
rigi
specif
posit
negativesens
read
repres
copyback
digenom
equal
distribut
along
end
mv
genom
figur
similar
ng
profil
copyback
di
genom
rigi
previous
observ
context
sendai
viru
infect
baum
et
al
studi
singl
popul
ntslong
copyback
di
rna
genom
specif
enrich
rigi
thu
concord
result
rigi
baum
et
al
studi
nice
confirm
relev
strategi
futur
deeper
ng
studi
done
explain
rigirna
sampl
collect
mv
infect
possess
immunostimulatori
activ
despit
absenc
mv
rna
ligand
specif
bound
rigi
figur
propos
selfrna
molecul
process
action
antivir
endoribonucleas
rnasel
cellular
rna
could
specif
rna
ligand
bind
rigi
induc
express
inde
rnasel
induc
type
ifn
via
product
shortlength
rna
molecul
viral
cellular
origin
mechan
includ
interact
rigi
malathi
et
al
current
experiment
setup
use
sampl
multiplex
allow
appropri
analysi
rel
long
viralderiv
rna
cellular
rna
molecul
altern
possibl
mv
rigispecif
rna
ligand
short
length
thu
compat
classic
illumina
ng
protocol
appli
studi
futur
protocol
adapt
studi
small
size
rlr
partner
studi
rlrspecif
cellular
partner
recent
deddouch
et
al
isol
pertin
agonist
coip
complex
purifi
cell
infect
emcv
positivesens
rna
viru
use
ng
map
rna
l
region
emcv
genom
numer
function
assay
perform
valid
l
region
key
determin
stimulatori
activ
deddouch
et
al
work
support
previou
studi
show
infect
cell
posit
cooper
venkataraman
et
al
satoh
et
al
brun
horvath
child
et
al
vitro
studi
suggest
hypothet
recogn
long
dsrna
molecul
like
poli
c
kato
et
al
bind
dsrna
stem
molecul
start
form
filament
toward
extrem
peisley
et
al
wu
et
al
recent
studi
autoimmun
disord
propos
detect
aberr
secondari
structur
form
self
mrna
liddicoat
et
al
evid
certainli
natur
ligand
rna
stem
structur
embed
within
differ
rna
concord
result
show
recogn
integr
mvn
mrna
certainli
recognit
stem
loop
structur
silico
mfold
predict
rna
secondari
structur
within
differ
part
mv
genom
suggest
mvn
mrna
potenti
form
stem
loop
structur
figur
recent
shown
stabil
shorter
filament
around
dsrna
nt
length
brun
et
al
data
confirm
synergi
demonstr
upon
mv
infect
bind
similar
viral
rna
ligand
inde
specif
rna
encompass
mvn
segment
figur
b
howev
whole
mvn
mrna
bound
read
mostli
local
end
n
region
furthermor
transfect
vitro
transcrib
rna
correspond
region
mv
genom
human
epitheli
cell
identifi
higher
immunostimulatori
activ
end
n
mrna
compar
rna
fragment
similar
size
come
elsewher
genom
figur
data
suggest
upon
mv
infect
specif
interact
rna
agonist
could
involv
stabil
short
filament
form
secondari
structur
local
end
mvn
mrna
summari
use
onestreprlr
affin
chromatographi
purif
ng
provid
first
simultan
visualis
specif
rna
ligand
rigi
live
cell
presenc
differ
rna
virus
result
show
cytosol
sensor
individu
rna
profil
upon
infect
differ
rna
virus
figur
previou
studi
demonstr
rigi
specif
bind
au
polyuucrich
region
viral
genom
saito
et
al
schnell
et
al
rung
et
al
kell
et
al
result
rlrspecif
bind
simpli
explain
primari
rna
composit
augc
content
rna
ligand
inde
found
rigi
preferenti
bind
aurich
sequenc
figur
bind
observ
dsrnacontain
di
genom
produc
recombin
result
suggest
rigi
recogn
specif
rna
secondari
structur
specif
aurich
rna
less
pronounc
figur
b
addit
studi
perform
obtain
clearer
view
similar
differ
rna
structur
recogn
three
rlr
current
appli
onestreprlr
approach
three
rna
virus
well
intracellular
bacterium
consequ
work
offer
new
strategi
immun
antivir
therapi
target
rlr
pathway
therapeut
control
viral
infect
enhanc
immun
respons
vaccin
conceiv
strategi
immun
suppress
control
inflamm
specif
autoimmun
diseas
human
embryon
kidney
atcc
hela
human
cervix
adenocarcinoma
epitheli
atcc
cell
human
lung
adenocarcinoma
epitheli
atcc
maintain
dmemglutamax
gibco
thermo
fisher
scientif
waltham
massachusett
supplement
heatinactiv
fc
invitrogen
thermo
fisher
scientif
waltham
massachusett
penicillinstreptomycin
gibco
monocyt
cell
atcc
cultur
cellsml
rpmi
gibco
contain
heatinactiv
fc
penicillinstreptomycin
cell
line
mycoplasma
contamin
test
statu
routin
verifi
atcc
establish
clonal
stabl
cell
line
express
onestrlr
use
modifi
plasmid
carri
gw
cassett
kindli
provid
dr
yve
jacob
de
de
viru
arn
institut
pasteur
first
rlr
sequenc
rigi
amplifi
standard
pcr
human
spleen
cdna
librari
invitrogen
use
specif
primer
sequenc
includ
supplementari
file
correspond
dna
fragment
clone
vitro
recombin
entri
vector
bp
reaction
gateway
invitrogen
rlr
gene
rigi
final
recombin
onestreptag
vitro
recombin
lr
reaction
new
plasmid
transfect
cell
use
jetprim
reagent
polyplu
transfect
strasbourg
franc
two
day
later
cultur
medium
remov
replac
fresh
medium
contain
sigma
st
loui
missouri
transfect
cell
amplifi
subsequ
clone
serial
limit
dilut
least
clone
screen
rlr
detect
tag
protein
express
qpcr
western
blot
cell
line
gener
lentivir
vector
use
canon
tripl
transfect
cell
vsvg
envelop
encapsid
plasmid
kindli
provid
dr
pierr
charneau
zufferey
et
al
pgipz
vector
plasmid
thermo
scientif
waltham
massachusett
express
either
shrna
target
shneg
target
rigi
shrigi
bear
puromycin
select
marker
vector
titrat
accord
manufactur
instruct
hela
cell
isr
report
cell
line
lucashourani
et
al
transduc
moi
hr
later
puromycin
ad
media
select
properli
transduc
cell
chikv
strain
isol
serum
adult
patient
arthralgia
myalgia
saint
loui
citi
franc
decemb
schuffeneck
et
al
chikv
strain
titrat
vero
cell
tissu
cultur
infect
dose
recombin
chikvrluc
contain
rluc
report
gene
insert
nonstructur
protein
alreadi
describ
henrik
gad
et
al
attenu
mv
schwarz
vaccin
strain
mv
recombin
mv
schwarz
express
fluc
addit
transcript
unit
deriv
mv
previous
describ
combredet
et
al
komarova
et
al
prevent
v
protein
express
mv
twostep
pcr
strategi
use
gener
viru
two
pcr
fragment
amplifi
use
atctgctcccatctctatgg
tctgtgcccttcttaatggg
first
fragment
cccattaagaagggcacaga
aggttgtactagttgggtcg
second
fragment
pcr
introduc
mutat
interf
rna
edit
uuaaaaagggcacaga
nativ
sequenc
mutat
uuaagaagggcacaga
two
pcr
product
combin
second
pcr
reaction
use
primer
produc
mutat
hindiiispei
mv
fragment
move
ptmmvschwarz
plasmid
digest
correspond
restrict
enzym
recombin
viru
rescu
previous
describ
combredet
et
al
name
immunoblot
analysi
perform
valid
lack
mvv
express
data
shown
viru
stock
produc
vero
cell
titrat
protein
extract
resolv
sdspolyacrylamid
gel
electrophoresi
criterion
gel
biorad
hercul
california
mop
run
buffer
transfer
cellulos
membran
ge
healthcar
littl
chalfont
unit
kingdom
criterion
blotter
system
biorad
follow
antibodi
use
antistreptag
qiagen
hilden
germani
novu
littleton
colorado
cell
signal
danver
massachusett
enzolifesci
new
york
ny
antirigi
cell
signal
monoclon
antibodi
sigma
cell
signal
abcam
cambridg
uk
hrpcoupl
antimous
ge
healthcar
antirabbit
ge
healthcar
use
secondari
antibodi
peroxidas
activ
visual
ecl
plu
western
blot
detect
system
ge
healthcar
mv
intracellular
stain
perform
mous
antin
mab
clone
giraudon
wild
fitc
coupl
goat
antimous
ab
bd
bioscienc
franklin
lake
new
jersey
chikv
intracellular
stain
perform
either
fitcconjug
mab
et
al
antidsrna
mab
scicon
hungari
follow
antimouseapc
antibodi
invitrogen
cell
x
per
well
plate
plate
infect
appropri
moi
chikvrluc
infect
time
point
cell
lyse
passiv
lysi
buffer
promega
fitchburg
wisconsin
luciferas
activ
measur
brightglow
luciferas
assay
system
promega
renilla
glow
luciferas
assay
system
promega
correspondingli
immunostain
cell
wash
twice
phosphatebuff
salin
pb
foetal
calf
serum
fc
fix
pb
contain
paraformaldehyd
cell
permeabil
permwash
buffer
bd
bioscienc
incub
primari
antibodi
min
wash
permwash
incub
secondari
antibodi
cell
wash
twice
pb
fc
analysi
flow
cytometri
use
macsquant
cytomet
miltenyi
biotec
bergisch
gladbach
germani
analysi
done
softwar
flowjo
ver
strlr
cell
infect
moi
hr
mv
hr
chikv
cell
wash
twice
cold
pb
lyse
ml
lysi
buffer
mm
mopskoh
mm
kcl
igep
mm
supplement
unitml
rnasin
promega
complet
proteas
inhibitor
cocktail
roch
penzberg
germani
cell
lysat
incub
ice
min
gentl
mix
everi
min
clarifi
centrifug
g
min
aliquot
cell
lysat
use
perform
total
rna
purif
use
tri
reagent
ls
sigma
remain
cell
lysat
incub
hr
spin
wheel
streptactin
sepharos
high
perform
bead
ge
healthcar
bead
collect
centrifug
g
min
wash
twice
min
spin
wheel
ml
wash
buffer
mm
mopskoh
mm
kcl
mm
supplement
unitml
rnasin
complet
proteas
inhibitor
cocktail
precipit
elut
use
biotin
elut
buffer
iba
rna
purif
perform
use
tri
reagent
ls
sigma
rna
dissolv
dnasefre
rnasefre
ultrapur
water
extract
rna
analyz
use
nanovu
ge
healthcar
bioanalys
rna
nano
kit
agil
santa
clara
california
rna
molecul
isol
strlrrna
complex
treat
librari
prepar
use
truseq
strand
mrna
sampl
prepar
kit
illumina
san
diego
california
accord
manufactur
instruct
analyz
rna
speci
present
initi
poli
rna
isol
step
omit
briefli
fragment
rna
sampl
randomli
prime
revers
transcript
follow
secondstrand
synthesi
creat
doublestrand
cdna
fragment
end
repair
step
necessari
adenin
ad
specif
illumina
adapt
ligat
ligat
product
submit
pcr
amplif
sequenc
perform
illumina
platform
gener
singleend
bp
read
bear
strand
specif
sequenc
read
clean
adapt
sequenc
low
complex
sequenc
see
appendix
read
align
mv
schwarz
strain
refer
genom
http
strain
refer
genom
http
use
bowti
option
best
q
chunkmb
langmead
et
al
first
posit
read
take
account
strand
use
statist
analysi
use
knime
softwar
jagla
et
al
count
per
posit
calcul
use
pileup
samtool
li
et
al
read
clean
perform
use
version
cleanng
http
singleend
mode
follow
paramet
threshold
threshold
ascii
valu
adapt
sequenc
tggaattctcgggtgccaagg
tggaattctcgggtgccaaggaactccagtcacnnnnnnatctcgtatgccgtcttctgcttg
paramet
sequenc
ident
min
ident
adapt
read
qc
threshold
ascii
valu
base
valu
inferior
consid
match
adapt
remov
mani
adapt
possibl
min
truncat
adapt
truncat
adapt
end
leader
sequenc
use
adapt
sequenc
regular
adapt
end
statist
analys
perform
r
version
team
bioconductor
packag
normal
differenti
analys
carri
rlrrna
chrna
one
hand
total
rlr
rna
total
ch
rna
hand
case
normal
perform
version
normal
paramet
locfun
shorth
default
paramet
otherwis
love
et
al
differenti
analysi
use
default
set
raw
pvalu
adjust
accord
bh
procedur
benjamini
hochberg
adjust
pvalu
consid
signific
lower
posit
interest
enrich
read
rlrrna
compar
chrna
enrich
total
rna
comparison
au
content
calcul
slide
window
nt
step
compar
mean
count
within
nt
window
sum
sequenc
read
extend
nt
viral
rna
sequenc
subject
secondari
structur
predict
use
mfold
softwar
version
use
standard
paramet
slide
window
window
size
step
refer
genom
copyback
dirna
amplifi
rna
extract
total
rna
extract
strigi
use
two
set
mv
primer
shingai
et
al
dirna
tataagcttaccagacaaagctgggaatagaaacttcg
c
cgaagatattctggtgtaagtctagta
standard
genom
b
tttatccagaatctcaagtccgg
revers
transcript
perform
super
script
iii
invitrogen
pcr
amplif
achiev
highfidel
master
mix
neb
ipswich
massachusett
pcramplifi
product
ac
clone
ptopo
vector
invitrogen
sequenc
rlr
mrna
express
profil
strlr
cell
perform
rtqpcr
total
rna
isol
rneasi
mini
kit
qiagen
reaction
perform
ng
rna
use
taqman
rnatoct
kit
appli
biosystem
waltham
massachusett
custom
taqman
gene
express
assay
rigi
gapdh
use
appli
biosystem
steponeplustm
system
result
normal
use
express
level
gapdh
housekeep
gene
rlr
express
level
cell
settl
gene
express
measur
perform
triplic
analys
steponeplustm
softwar
rlrrna
enrich
profil
rna
extract
tri
reagent
ls
affin
chromatographi
purif
streptactin
sepharos
start
ng
rna
cdna
synthesi
achiev
use
superscript
vilo
cdna
synthesi
kit
life
technolog
thermo
fisher
scientif
waltham
massachusett
follow
manufactur
recommend
reaction
perform
ng
cdna
use
power
green
pcr
master
mix
life
technolog
reaction
perform
final
volum
presenc
appropri
primer
supplementari
file
mv
chikv
specif
primer
design
use
primer
express
softwar
appli
biosystem
rna
fold
enrich
calcul
accord
follow
formula
fold
enrich
fe
fe
ct
ct
queri
ct
gapdh
bead
ct
queri
ct
gapdh
total
normal
fold
enrich
nfe
nfe
primer
rlrfe
primer
mcherryf
primer
short
rna
molecul
obtain
pcineo
plasmid
linear
xbai
transcript
transcript
reaction
carri
ribomax
express
larg
scale
rna
product
system
promega
rna
purifi
use
tril
reagent
analyz
bioanalys
rna
nano
kit
agil
poli
c
amersham
bioscienc
amersham
uk
determin
strlr
respons
synthet
ligand
express
determin
transient
transfect
report
plasmid
contain
fluc
gene
control
promot
lin
et
al
rna
transfect
analysi
strlr
cell
plate
plate
x
per
well
hr
cell
transfect
jetprim
reagent
ngwell
plasmid
harbour
thymidin
kinas
tk
promot
upstream
rluc
gene
ptkrluc
ngwell
ng
either
poli
c
hr
cell
lyse
fluc
rluc
activ
measur
cell
lysat
use
dualluciferas
report
assay
system
promega
accord
manufactur
instruct
report
activ
calcul
triplic
ratio
fluc
activ
refer
rluc
activ
determin
immunostimulatori
activ
rlr
rna
partner
cell
plate
one
day
transfect
cell
per
well
rlrspecif
total
rna
ng
transfect
use
jetprim
togeth
ng
pcineo
empti
vector
carrier
hr
posttransfect
cell
lyse
passiv
buffer
fluc
activ
measur
use
brightglo
luciferas
assay
system
viral
sequenc
synthes
use
specif
primer
supplementari
file
forward
primer
present
promot
sequenc
attgtaatacgactcactataggg
extrem
amplicon
purifi
agaros
gel
use
vitro
transcript
desir
rna
molecul
separ
extens
byproduct
trianaalonso
et
al
tbeurea
polyacrylamid
gel
biorad
purifi
rna
analyz
bioanalys
rna
pico
kit
agil
ng
purifi
rna
transfect
cell
mrna
quantifi
rtqpcr
analysi
similar
rung
et
al
immunoprecipit
protocol
use
littl
modif
without
crosslink
mm
mopskoh
mm
kcl
igep
mm
supplement
unitml
rnasin
complet
proteas
inhibitor
cocktail
buffer
use
cell
lysi
wash
step
